Maintenance of surgically induced remission of Crohn's disease

Digestion

Volumn 76, Issue 2, 2008, Pages 130-135

  Froehlich, Florian ^a,b,d   Juillerat, Pascal ^a   Pittet, Valérie ^c   Felley, Christian ^a   Mottet, Christian ^a   Vader, John Paul ^c   Michetti, Pierre ^a   Gonvers, Jean Jacques ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

Author keywords

Azathioprine; Crohn's disease; Immunosuppressive treatment; Maintenance treatment; Mesalazine; Postoperative treatment; Relapse prevention

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; INFLIXIMAB; INTERLEUKIN 10; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; ORNIDAZOLE; PLACEBO; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE;

CLINICAL TRIAL; COLONOSCOPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PREVENTION AND CONTROL; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK FACTOR; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROHN DISEASE; DRUG THERAPY, COMBINATION; ENDOSCOPY, GASTROINTESTINAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; POSTOPERATIVE CARE; RECURRENCE; RISK FACTORS; SMOKING;

EID: 38849119881     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111027     Document Type: Review

References (55)

1. Froehlich F, Juillerat P, Felley C, Mottet C, Vader JP, Burnand B, Michetti P, Gonvers JJ: Treatment of postoperative Crohn's disease. Digestion 2005;71:49-53.
2. Becker JM: Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1999;28:371-390, viii-ix.
3. Mekhjian HS, Switz DM, Watts HD, Deren JJ, Katon RM, Beman FM: National Cooperative Crohn's Disease Study: factors determining recurrence of Crohn's disease after surgery. Gastroenterology 1979;77:907-913.
4. Bernell O, Lapidus A, Hellers G: Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000;231:38-45.
5. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M: Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-963.
6. Sachar DB: The problem of postoperative recurrence of Crohn's disease. Med Clin North Am 1990;74:183-188.
7. Bergman L, Krause U: Postoperative treatment with corticosteroids and salazosulphapyridine (salazopyrin) after radical resection for Crohn's disease. Scand J Gastroenterol 1976;11:651-656.
8. Banerjee S, Peppercorn MA: Inflammatory bowel disease. Medical therapy of specific clinical presentations. Gastroenterol Clin North Am 2002;31:185-202, x.
9. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G: Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984;25:665-672.
10. Greenstein AJ, Sachar DB, Pasternack BS, Janowitz HD: Reoperation and recurrence in Crohn's colitis and ileocolitis crude and cumulative rates. N Engl J Med 1975;293:685-690.
11. Whelan G, Farmer RG, Fazio VW, Goormastic M: Recurrence after surgery in Crohn's disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology 1985;88:1826-1833.
12. D'Haens G: Prevention of postoperative recurrence in Crohn's disease. Curr Gastroenterol Rep 1999;1:476-481.
13. Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, Traina M, Tonelli F, Pagliaro L: Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994;106:643-648.
14. Sutherland LR, Ramcharan S, Bryant H, Fick G: Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990;98:1123-1128.
15. Borley NR, Mortensen NJ, Jewell DP: Preventing postoperative recurrence of Crohn's disease. Br J Surg 1997;84:1493-1502.
16. Kane SV, Flicker M, Katz-Nelson F: Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission. J Clin Gastroenterol 2005;39:32-35.
17. Ryan WR, Allan RN, Yamamoto T, Keighley MR: Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence. Am J Surg 2004;187:219-225.
18. Hellers G: Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir Scand Suppl 1979;490:1-84.
19. Baker WN: The results of ileorectal anastomosis at St Mark's Hospital from 1953 to 1968. Gut 1970;11:235-239.
20. Michelassi F, Balestracci T, Chappell R, Block GE: Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg 1991;214:230-240.
21. Griffiths AM, Wesson DE, Shandling B, Corey M, Sherman PM: Factors influencing postoperative recurrence of Crohn's disease in childhood. Gut 1991;32:491-495.
22. Caprilli R, Corrao G, Taddei G, Tonelli F, Torchio P, Viscido A: Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon Rectum 1996;39:335-341.
23. D'Haens GR, Gasparaitis AE, Hanauer SB: Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease. Gut 1995;36:715-717.
24. Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, Aufses AH Jr: Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988;29:588-592.
25. Lautenbach E, Berlin JA, Lichtenstein GR: Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 1998;115:259-267.
26. Aeberhard P, Berchtold W, Riedtmann HJ, Stadelmann G: Surgical recurrence of perforating and nonperforating Crohn's disease. A study of 101 surgically treated patients. Dis Colon Rectum 1996;39:80-87.
27. Avidan B, Sakhnini E, Lahat A, Lang A, Koler M, Zmora O, Bar-Meir S, Chowers Y: Risk factors regarding the need for a second operation in patients with Crohn's disease. Digestion 2005;72:248-253.
28. Fazio VW, Marchetti F, Church M, Goldblum JR, Lavery C, Hull TL, Milsom JW, Strong SA, Oakley JR, Secic M: Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial. Ann Surg 1996;224:563-571.
29. Ewe K, Bottger T, Buhr HJ, Ecker KW, Otto HF: Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999;11:277-282.
30. Ewe K, Herfarth C, Malchow H, Jesdinsky HJ: Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion 1989;42:224-232.
31. Nygaard K, Fausa O: Crohn's disease. Recurrence after surgical treatment. Scand J Gastroenterol 1977;12:577-584.
32. Caprilli R, Andreoli A, Capurso L, Corrao G, D'Albasio G, Gioieni A, Assuero Lanfranchi G, Paladini I, Pallone F, Ponti V, et al: Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 1994;8:35-43.
33. Brignola C, Cottone M, Pera A, Ardizzone S, Scribano ML, De Franchis R, D'Arienzo A, D'Albasio G, Pennestri D: Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology 1995;108:345-349.
34. Florent C, Cortot A, Quandale P, Sahmound T, Modigliani R, Sarfaty E, Valleur P, Dupas JL, Daurat M, Faucheron JL, Lerebours E, Michot F, Belaiche J, Jacquet N, Soule JC, Rothman N, Gendre JP, Malafosse M: Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol 1996;8:229-233.
35. McLeod RS, Wolff BG, Steinhart AH, Carryer PW, O'Rourke K, Andrews DF, Blair JE, Cangemi JR, Cohen Z, Cullen JB, et al: Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995;109:404-413.
36. Sutherland LR, Martin F, Bailey RJ, Fedorak RN, Poleski M, Dallaire C, Rossman R, Saibil F, Lariviere L: A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology 1997;112:1069-1077.
37. Lochs H, Mayer M, Fleig WE, Mortensen PB, Bauer P, Genser D, Petritsch W, Raithel M, Hoffmann R, Gross V, Plauth M, Staun M, Nesje LB: Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 2000;118:264-273.
38. Camma C, Giunta M, Rosselli M, Cottone M: Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997;113:1465-1473.
39. Cottone M, Camma C: Mesalamine and relapse prevention in Crohn's disease. Gastroenterology 2000;119:597.
40. Caprilli R, Cottone M, Tonelli F, Sturniolo G, Castiglione F, Annese V, Papi C, Viscido A, Camma C, Corrao G, Latella G: Two mesalazine regimens in the prevention of the postoperative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther 2003;17:517-523.
41. Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn MA, Thisted RA, Cohen RD, Present DH: Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004;127:723-729.
42. Nos P, Hinojosa J, Aguilera V, Moles JR, Pastor M, Ponce J, Berenguer J: Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease (in Spanish). Gastroenterol Hepatol 2000;23:374-378.
43. D'Haens G, Geboes K, Ponette E, Penninckx F, Rutgeerts P: Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology 1997;112:1475-1481.
44. Ardizzone S, Maconi G, Sampietro GM, Russo A, Radice E, Colombo E, Imbesi V, Molteni M, Danelli PG, Taschieri AM, Bianchi Porro G: Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004;127:730-740.
45. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P: Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262-267.
46. Rutgeerts P, Hiele M, Geboes K, Peeters M, Penninckx F, Aerts R, Kerremans R: Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617-1621.
47. Rutgeerts P, Van Assche G, Vermeire S, D'Haens G, Baert F, Noman M, Aerden I, De Hertogh G, Geboes K, Hiele M, D'Hoore A, Penninckx F: Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005;128:856-861.
48. Colombel JF, Ricart E, Loftus EV Jr, Tremaine WJ, Young-Fadok T, Dozois EJ, Wolff BG, Devine R, Pemberton JH, Sandborn WJ: Management of Crohn's disease of the ileoanal pouch with infliximab. Am J Gastroenterol 2003;98:2239-2244.
49. Sorrentino D, Terrosu G, Avellini C, Beltrami CA, Bresadola V, Toso F: Prevention of postoperative recurrence of Crohn's disease by infliximab. Eur J Gastroenterol Hepatol 2006;18:457-459.
50. Biancone L, Cretella M, Tosti C, Palmieri G, Petruzziello C, Geremia A, Calabrese E, Pallone F: Local injection of infliximab in the postoperative recurrence of Crohn's disease. Gastrointest Endosc 2006;63:486-492.
51. Hellers G, Cortot A, Jewell D, Leijonmarck CE, Lofberg R, Malchow H, Nilsson LG, Pallone F, Pena S, Persson T, Prantera C, Rutgeerts P: Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology 1999;116:294-300.
52. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C: Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002;51:405-409.
53. Marteau P, Lemann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y, Cadiot G, Soule JC, Bourreille A, Metman E, Lerebours E, Carbonnel F, Dupas JL, Veyrac M, Coffin B, Moreau J, Abitbol V, Blum-Sperisen S, Mary JY: Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut 2006;55:842-847.
54. Van Gossum A, Dewit O, Louis E, de Hertogh G, Baert F, Fontaine F, DeVos M, Enslen M, Paintin M, Franchimont D: Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection. Inflamm Bowel Dis 2007;13:135-142.
55. Colombel JF, Rutgeerts P, Malchow H, Jacyna M, Nielsen OH, Rask-Madsen J, Van Deventer S, Ferguson A, Desreumaux P, Forbes A, Geboes K, Melani L, Cohard M: Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 2001;49:42-46.